Atlas Trials

Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis

Clinical trial NCT07499791 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07499791
Sponsor
Beijing Tongren Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Dacryocystitis
Start date
2026-05-01
Primary completion
2027-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.